SCHEMBL7666197

SCHEMBL7666197

CCCCn1cnc2c(OCCF)nc(Nc3cnc4ccccc4c3)nc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 8/20 0.40
▸ CCNE1 P24864 7/20 0.40
▸ PDGFRA P16234 6/20 0.40
▸ CCNE2 O96020 1/20 0.38
▸ IGF1R P08069 7/20 0.37
▸ EGFR P00533 1/20 0.37
▸ INSR P06213 1/20 0.37
▸ MET P08581 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ TEK Q02763 1/20 0.37
▸ TRPV1 Q8NER1 2/20 0.36
▸ CTSL P07711 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ TMIGD3 P0DMS9 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ ADORA1 P30542 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7666193 0.94 CDK2 (0.41) CDK2CCNE1PDGFRACCNE2IGF1R
SCHEMBL7666399 0.91 CDK2 (0.40) CDK2CCNE1PDGFRAIGF1REGFR
SCHEMBL7664310 0.91 CDK2 (0.42) CDK2CCNE1PDGFRACCNE2IGF1R
SCHEMBL7670174 0.88 CDK2 (0.40) CDK2CCNE1PDGFRACCNE2IGF1R
SCHEMBL7672070 0.87 CDK2 (0.41) CDK2CCNE1PDGFRACCNE2IGF1R
SCHEMBL7668416 0.86 CCNE1 (0.41) CDK2CCNE1PDGFRACCNE2IGF1R
SCHEMBL7672349 0.85 SLC29A1 (0.43) CDK2CCNE1PDGFRAIGF1REGFR
SCHEMBL7666161 0.82 PDGFRA (0.41) CDK2CCNE1PDGFRAEGFRCTSL
SCHEMBL7356565 0.82 PDGFRA (0.38) CDK2CCNE1PDGFRACTSLADORA2A
SCHEMBL7667654 0.80 CCNE1 (0.53) CDK2CCNE1PDGFRACCNE2CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 — — US claimed
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 — — US disclosed
Send feedback